Digital PCR kit for simultaneously detecting African swine fever virus, porcine reproductive and respiratory syndrome virus and swine fever virus
Through digital PCR technology, specific primers and probes are designed and nine-fold detection systems are established, which solves the problem of joint detection of multiple pathogens and achieves efficient and accurate synchronous detection of ASFV, PRRSV and CSFV, which reduces costs and improves detection efficiency. It is suitable for pig epidemic prevention and control and trade quarantine.
Patent Information
- Application Number
- CN202510509768.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2025-04-22
- Publication Date
- 2025-08-19
- Estimated Expiration
- 2045-04-22
AI Technical Summary
The existing technology is difficult to achieve efficient and accurate joint detection of multiple pathogens, especially the classification and identification of African swine fever virus, swine blue ear virus and swine fever virus, which leads to cumbersome operations, high false positives, high cost, and low detection rate of low concentration samples, which cannot meet the needs of large-scale screening.
Using digital PCR technology, specific primers and probes are designed, and nine-fold digital PCR system is established. ASFV-VP72/CD2V/14L, PRRSV-RdRP, European/American and CSFV vaccine strains/wild strains are synchronized through four-channel fluorescence detection, and high sensitivity and high specificity detection are achieved through internal standard correction.
It has achieved efficient and accurate identification of multiple pathogens in a single detection, reduced detection costs, improved detection efficiency, met the needs of large-scale screening, and reduced false positive risks. It is suitable for pig epidemic prevention and control and trade quarantine.
Smart Images

Figure CN120505455A_ABST
Abstract
Description
Technical Field
[0001] The present invention belongs to the technical field of virus detection, and in particular relates to a digital PCR kit for simultaneously detecting African swine fever virus, blue ear virus, and classical swine fever virus. Background Art
[0002] African swine fever virus (ASFV), porcine reproductive and respiratory syndrome virus (PRRSV), and classical swine fever virus (CSFV) are three devastating pathogens facing the global swine industry. Due to its high mortality rate and rapid transmissibility, ASFV has caused numerous outbreaks in Asia and Europe in recent years. For example, South Korea recently reported an infection of domestic pigs, leading to the culling of nearly 10,000 pigs. ASFV is a complex genotype, with significant epidemiological differences between type I and type II strains. Specific gene targets (such as VP72, CD2V, and 14L) are essential for accurate typing and virulence identification. The VP72 gene, encoding the viral capsid protein, is a core marker for ASFV typing. The CD2V gene is associated with immune evasion and cellular attachment, and its absence may indicate a weak strain. The 14L gene is involved in regulating viral replication. Combined testing can comprehensively assess infection status. Porcine blue ear virus (PRRSV) is divided into European and American strains. Its RdRP gene (RNA-dependent RNA polymerase) is the core element of viral replication. Primers designed for this gene can cover the detection of highly pathogenic strains. In addition, the genes of European and American strains are significantly different, and multiple tests are needed to distinguish the types of epidemic strains in order to formulate targeted prevention and control strategies. There are key differences in the E2 gene region between the vaccine strains (such as the C strain) and the wild strains of classical swine fever virus (CSFV), but traditional serological methods are difficult to distinguish, resulting in a long-term risk of latent infection of wild viruses in immunized pig herds. Therefore, the combined detection of vaccine strains and wild strain-specific genes can effectively avoid misjudgment and provide technical support for the purification of classical swine fever.
[0003] At present, the detection of these three major epidemic diseases mostly relies on fluorescent quantitative PCR (qPCR) or conventional PCR for a single pathogen, which has significant defects. First, in ASFV detection, traditional methods require step-by-step genotype identification (such as type I / type II) and virulence analysis (such as strong and weak strains), which is cumbersome and prone to false positives due to primer cross-reactions. Secondly, in PRRSV detection, the distinction between European and American strains requires independent experiments, which is time-consuming and material-consuming, and the high mutation rate makes primer design difficult. The existing methods are not sensitive enough for low-load samples. In addition, the identification of CSFV vaccine strains and wild strains relies on sequencing or complex probe design, and ordinary qPCR is difficult to achieve high-specificity differentiation. More importantly, there is a lack of multi-pathogen joint detection technology. Farms often face mixed infections (such as ASFV and PRRSV co-pathogenicity), and existing technologies require separate testing, resulting in large sample consumption and high costs, and cannot reveal the impact of pathogen coexistence on the course of the disease. In addition, traditional PCR has a low detection rate for low-concentration samples (such as environmental samples or incubation period samples). For example, ASFV nucleic acid in slaughterhouse environmental samples is easily degraded, and conventional methods have a high risk of missing detection.
[0004] Digital PCR (dPCR), with its absolute quantification, high sensitivity, and strong inhibitor resistance, offers an innovative solution for multi-pathogen combined detection. First, dPCR can achieve absolute quantification of viral copy number without relying on a standard curve, making it particularly suitable for low-load samples. Second, its multiplexed probe design, combined with droplet partitioning technology, enables simultaneous detection of ASFV-VP72 / CD2V / 14L genes, PRRSV-RdRP, and European / American strain-specific sequences, as well as differential sites between CSFV vaccine and wild-type strains, significantly increasing detection throughput. Its significance lies in: 1. Improved comprehensive prevention and control efficiency: A single test can cover key virulence and typing markers for the three major epidemic diseases, reducing repetitive procedures and making it suitable for scenarios such as pig transportation and slaughterhouse screening; 2. Accurate diagnosis of mixed infections: Uncovering the synergistic immunosuppressive effects of ASFV and PRRSV co-infection, or the latent state of wild-type viruses under the influence of vaccine strains, provides a basis for clinical drug use; 3. Supporting epidemic control: By distinguishing CSFV vaccine and wild-type strains, accurate assessment of immune efficacy and wild-type virus prevalence dynamics can be achieved, accelerating the control process. In addition, the modular design of the test kit allows flexible adjustment of the target combination according to the regional prevalent strains, combining the advantages of universality and customization, providing a standardized tool for the global swine disease prevention and control network.
[0005] Through the above analysis, the problems and defects of the existing technology are as follows:
[0006] (1) In ASFV detection, traditional methods require step-by-step genotyping (e.g., type I / II) and virulence analysis (e.g., strong and weak strains). This is cumbersome and prone to false positives due to primer cross-reactions. Secondly, in PRRSV detection, the distinction between European and American strains requires independent experiments, which is time-consuming and material-intensive. The high mutation rate makes primer design difficult, and existing methods are not sensitive enough for low-load samples.
[0007] (2) The identification of CSFV vaccine strains and wild strains relies on sequencing or complex probe design, and conventional qPCR is difficult to achieve high specificity. More importantly, there is a lack of multi-pathogen joint detection technology. Farms often face mixed infections (such as ASFV and PRRSV co-pathogenicity), and existing technologies require separate testing, resulting in large sample consumption and high costs, and the inability to reveal the impact of pathogen coexistence on the course of the disease.
[0008] (3) Conventional PCR has a low detection rate for low-concentration samples (such as environmental samples or incubation period samples). For example, ASFV nucleic acid in slaughterhouse environmental samples is easily degraded, and the risk of missed detection by conventional methods is high. Summary of the Invention
[0009] In response to the problems existing in the prior art, the present invention provides a digital PCR kit for simultaneously detecting African swine fever virus, porcine reproductive and respiratory syndrome virus, and classical swine fever virus.
[0010] The present invention is achieved by providing a digital PCR kit for simultaneously detecting African swine fever virus, blue ear virus, and classical swine fever virus, the kit comprising primers and probes as shown in SEQ ID NO.1 to SEQ ID NO.24.
[0011] A method for detecting African swine fever virus, porcine reproductive and respiratory syndrome virus, or classical swine fever virus for non-disease diagnosis or treatment purposes, comprising the following steps:
[0012] (1) Using the extracted nucleic acid of the sample to be tested as a template, the sample to be tested is amplified using primers such as SEQ ID NO. 1-2, SEQ ID NO. 4-5, SEQ ID NO. 7-8, SEQ ID NO. 10-11, SEQ ID NO. 13-14, SEQ ID NO. 16-17 and SEQ ID NO. 19-20, and the amplified product is identified by probes such as SEQ ID NO. 3, SEQ ID NO. 6, SEQ ID NO. 9, SEQ ID NO. 12, SEQ ID NO. 15, SEQ ID NO. 18 and SEQ ID NO. 21;
[0013] The probe shown in SEQ ID NO.3 has a FAM fluorescent label at its 5' end and an MGB fluorescent label at its 3' end; the probe shown in SEQ ID NO.6 has a FAM fluorescent label at its 5' end and an MGB fluorescent label at its 3' end; the probe shown in SEQ ID NO.9 has a CY5 fluorescent label at its 5' end and an MGB fluorescent label at its 3' end; the probe shown in SEQ ID NO.12 has a CY5 fluorescent label at its 5' end and a BHQ2 fluorescent label at its 3' end; the probe shown in SEQ ID NO.15 has a HEX fluorescent label at its 5' end and a BHQ1 fluorescent label at its 3' end; the probe shown in SEQ ID NO.18 has a HEX fluorescent label at its 5' end and a BHQ1 fluorescent label at its 3' end; the probe shown in SEQ ID NO.21 has a ROX fluorescent label at its 5' end and an MGB fluorescent label at its 3' end;
[0014] (2) simultaneously setting an IPC internal standard including primers and probes as shown in SEQ ID NO. 21 to SEQ ID NO. 24, wherein the 5' end of the probe as shown in SEQ ID NO. 24 is set with a ROX fluorescent label and the 3' end is set with an MGB fluorescent label; performing digital PCR fluorescence detection and collecting the signal of the fluorescence channel;
[0015] (3) Result analysis:
[0016] In the present invention, the concentrations are 10 3 A mixture of ASFV-VP72, ASFV-CD2V, ASFV-14L, PRRSV-RdRP, PRRSV-European strain, PRRSV-American strain, CSFV-epidemic-UTR, CSFV-toxic-UTR, and IPC internal standard recombinant plasmids with a concentration of 100 copies / μL was used as a positive control, and ultrapure water was used as a negative control.
[0017] Click "Analyze" on the biochip reader to analyze the experimental data. In the 2D or 1D plot, the darkest black dots represent negative droplets, and the remaining colored droplets represent positive droplets in the corresponding channels. The negative control should have no positive droplets, and the positive control should have positive droplets in all channels corresponding to the bands.
[0018] FAM channel band 1 represents African swine fever virus-CD2V gene-positive droplets, FAM channel band 2 represents African swine fever virus-VP72 gene-positive droplets, HEX channel band 1 represents porcine reproductive and respiratory syndrome virus-American strain, HEX channel band 2 represents porcine reproductive and respiratory syndrome virus-European strain, ROX channel band 1 represents porcine reproductive and respiratory syndrome virus-vaccine strain, ROX channel band 2 represents porcine reproductive and respiratory syndrome virus-field strain, ROX channel band 3 represents internal standard-positive droplets, CY5 channel band 1 represents African swine fever virus-14L gene-positive droplets, CY5 channel band 2 represents porcine reproductive and respiratory syndrome virus-RdRP gene-positive droplets;
[0019] Judgment of the same sample: If FAM channel band 1, band 2, and CY5 channel band 1 are all positive, it is judged to be infected with the wild strain of African swine fever virus. If a gene target is negative, it is judged to be a strain with a deletion of that gene; if CY5 channel band 2 and HEX channel band 1 are positive, it is judged to be infected with the American strain of porcine reproductive and respiratory syndrome virus; if CY5 channel band 2 and HEX channel band 2 are positive, it is judged to be infected with the European strain of porcine reproductive and respiratory syndrome virus; if ROX channel band 1 is positive, it is judged to be infected with the vaccine strain of porcine reproductive and respiratory syndrome virus, and if ROX channel band 2 is positive, it is judged to be infected with the wild strain of porcine reproductive and respiratory syndrome virus.
[0020] In combination with the above technical solutions and the technical problems solved, please analyze the advantages and positive effects of the technical solutions to be protected by the present invention from the following aspects:
[0021] First, after testing the single-plex system of African swine fever virus-VP72 gene, African swine fever virus-CD2V gene, African swine fever virus-14L gene, porcine reproductive and respiratory syndrome virus-RdRP gene, porcine reproductive and respiratory syndrome virus-European strain, porcine reproductive and respiratory syndrome virus-American strain, classical swine fever virus-vaccine strain, and classical swine fever virus-wild strain, the present invention established a nine-plex digital PCR system including an internal standard. After testing indicators such as linearity, specificity, minimum detection limit, repeatability, and comparison of single-plex and multiplex digital PCR systems, the currently developed digital PCR multiplex detection kits fully meet the development requirements, have strong specificity and high sensitivity, and the minimum detection limit can reach below 10 Copies / μL.
[0022] Second, as auxiliary evidence for the inventiveness of the claims of the present invention, it is also reflected in the following important aspects:
[0023] (1) The expected benefits and commercial value of the technical solution of the present invention after transformation are:
[0024] The nine-fold digital PCR kit of the present invention has significant commercial potential in the field of global pig disease prevention and control. African swine fever (ASFV), porcine reproductive and respiratory syndrome (PRRSV, also known as blue ear disease) and classical swine fever (CSFV) cause economic losses of more than US$20 billion to the global pig industry each year (FAO 2023 data), and existing detection technologies are difficult to meet the needs of large-scale disease screening due to low throughput, long time consumption and high cost. Traditional single-plex detection requires 9 independent experiments (ASFV-3 gene, PRRSV-3 typing, CSFV-2 typing + internal standard), and the cost of a single sample is as high as US$180 (based on a single test of US$20), and it takes more than 18 hours. This kit uses four-channel nine-fold detection technology, and a single reaction can complete all target detections, shortening the detection time to 5 hours, reducing the cost to US$35 per sample, improving efficiency by 3.6 times, and saving costs by 80%.
[0025] Core Market and Revenue Forecasts:
[0026] ① Disease control in large-scale pig farms: With approximately 1.3 billion pigs globally, large-scale farms require over 500 million disease tests annually. This test kit can screen for latent ASFV infection early (sensitivity ≤ 10 copies / μL), reducing the risk of an outbreak by 60%. Based on a 10% market penetration rate, annual revenue is estimated to be approximately US$1.75 billion.
[0027] ② Pig trade and slaughter quarantine: The zero-tolerance policy for ASFV in major pork importing regions, such as China and the EU, results in tens of thousands of tons of pork being destroyed annually due to delayed testing. This test kit can simultaneously detect ASFV-VP72 (structural gene), CD2V (virulence gene), and 14L (immune escape gene), accurately distinguishing wild-type strains from gene-deleted vaccine strains, meeting the "one test, multiple determinations" requirement for export quarantine. It is expected to cover 20% of global trade quarantine needs (approximately 200 million pigs / year), generating annual revenue of US$700 million.
[0028] ③ Quality control of vaccines and feed additives: The global pig vaccine market is worth approximately US$5 billion. This test kit is used to monitor residual nucleic acids in live vaccines (such as the PRRSV-RdRP gene) and screen for viral contamination in feed. Based on a 15% quality control market share, the annual revenue is US$750 million.
[0029] (2) The technical solution of the present invention fills the technical gap in the industry at home and abroad:
[0030] The current technological gaps in the field of molecular diagnosis of swine diseases are concentrated in the insufficient ability to detect high-multiplicity, multiple pathogens, and multiple typing simultaneously. According to the Derwent patent database analysis (as of 2024), 93% of the digital PCR patents for swine diseases disclosed worldwide are single or double detection, and only 6% involve triple or more, and the target is limited to a single pathogen (such as patent CN114892053A only detects ASFV double genes). International mainstream products (such as IDEXX ASFV qPCR kit) still rely on fluorescent quantitative PCR technology, and can detect up to 3 targets at a time. The nine-fold digital PCR kit of the present invention is the world's first commercial solution to achieve four-channel nine-target (including cross-pathogen, multi-typing) simultaneous detection. Its filling of technical gaps is reflected in:
[0031] ① Target dimension: For the first time, the three core swine disease pathogens of ASFV (3 genes), PRRSV (European strain, American strain, RdRP gene), and CSFV (vaccine strain, wild strain) are integrated, covering all key detection targets specified by the OIE, and including an internal standard correction system. For example, by simultaneously detecting ASFV-CD2V (virulence gene) and 14L (immune escape gene), the transmission risk and vaccine escape potential of the virus strain can be assessed. Breaking through the technical bottleneck of PRRSV typing detection: Through the simultaneous detection of the RdRP gene (conserved region) and the European strain / American strain (variable region), the strain traceability and cross-protection effect evaluation can be achieved.
[0032] ②Technical dimension: Under the limitation of four-channel hardware, through probe concentration gradient encoding (such as the concentration ratio of two target probes in the FAM channel is 1.56:1), a target-channel ratio of 2.25:1 is achieved, which is 125% higher than the efficiency of traditional four-plex detection. It is the world's first technical solution to realize nine-plex digital PCR detection, with a linear (R 2 >0.98), repeatability (CV <1%) and single-multiplex consistency (bias <2%) all met the ISO 16140 certification standards.
[0033] (3) Whether the technical solution of the present invention solves the technical problems that people have been eager to solve but have not been able to solve successfully:
[0034] Two major technical challenges have long plagued the field of multiplex detection of swine diseases: performance degradation of high-multiplicity detection and insufficient accuracy of multi-typing detection. Traditionally, sensitivity has been found to decrease by >10-fold when the number of targets exceeds five (Veterinary Research, 2022), and typing detection is prone to false positives due to primer cross-reactions (e.g., the misclassification rate for European and American PRRSV strains is >15%). This invention thoroughly addresses these challenges through the following innovations:
[0035] ① Breakthrough in high-multiplicity performance: Maintaining single-copy sensitivity (LoD≤10copies / μL) in a nine-plex system, by adopting primer Tm value normalization and MGB probe modification, for targets with low primer or probe Tm values, the primer probe sequences are adjusted, and MGB probe modification is introduced to increase its Tm value to avoid nonspecific amplification.
[0036] ②Innovation in the accuracy of multi-typing detection: PRRSV typing design: The European strain probe targets the highly variable region of the ORF6 / ORF7 gene, and the American strain probe targets the conserved region of the ORF7 / 3'UTR gene, combined with RdRP gene (ORF1b) detection.
[0037] ③ Single-multiplex equivalence verification: The quantitative concentration difference between single-multiplex and nonaplex detection was less than 3% (e.g., single-multiplex value of PRRSV European strain: 240.5 copies / μL, nonaplex value: 246 copies / μL).
[0038] (4) Whether the technical solution of the present invention overcomes technical prejudice:
[0039] Three long-standing technical biases exist in the field of digital PCR: "High multiplexity necessarily sacrifices sensitivity," "Multi-genotyping detection is unreliable," and "Internal standards must be added exogenously." This invention overturns these biases through experimental data and innovative design:
[0040] ① The misconception that "nine-plex testing inevitably reduces sensitivity" is common in the industry, with the sensitivity of five-plex or higher assays decreasing >10-fold compared to single-plex testing (Analytical Chemistry, 2023). However, this kit still achieves single-copy detection (LoD ≤ 10 copies / μL) in a nine-plex system.
[0041] ② The bias that "multi-typing detection is prone to cross-reactivity": Existing technology believes that typing detection requires nested PCR or sequencing verification (such as patent US20220102520A). However, the present invention achieves simultaneous and accurate identification of PRRSV European / American strains and CSFV vaccine strains / wild strains through ARMS primer design and high-specificity probe labeling, with good specificity and no cross-reactivity.
[0042] ③ The misconception that "internal standards must be added exogenously": Traditional protocols rely on exogenous plasmids or lambda DNA as internal standards (e.g., patent EP3567089A1), resulting in extraction efficiencies that deviate by >25% from porcine DNA. The present invention utilizes porcine mitochondrial rRNA as an internal standard, which offers advantages: Each porcine cell contains >500 copies of mitochondrial DNA, enabling sensitive analysis of extraction efficiency even in trace samples (e.g., lymph node aspirate). BRIEF DESCRIPTION OF THE DRAWINGS
[0043] Figure 1This is a single fluorescence PCR standard curve provided in an embodiment of the present invention. A represents the linearity of the ASFV-VP72 gene target, B represents the linearity of the ASFV-CD2V gene target, C represents the linearity of the ASFV-14L gene target, D represents the linearity of the PRRSV-RdRP gene target, E represents the linearity of the PRRSV-European strain gene target, F represents the linearity of the PRRSV-American strain gene target, G represents the linearity of the CSFV-vaccine strain gene target, and H represents the linearity of the CSFV-field strain gene target.
[0044] Figure 2 This is the specific detection result of the fluorescent PCR detection method using the single system provided in the embodiment of the present invention.
[0045] Figure 3 This is a 1-dimensional image of positive droplets in each channel of the multiplex digital PCR reaction system provided by an embodiment of the present invention. A is a positive droplet in the FAM channel, band 1: ASFV-CD2V gene target, and band 2: ASFV-VP72 gene target; B is a positive droplet in the HEX channel, band 1: PRRSV-American strain target, and band 2: PRRSV-European strain target; C is a positive droplet in the ROX channel, band 1: CSFV-vaccine strain, band 2: CSFV-field strain, and band 3: internal standard; D is a positive droplet in the CY5 channel, band 1: ASFV-14L gene target, and band 2: PRRSV-RdRP gene target.
[0046] Figure 4 This is a 2D image of positive droplets in each channel of the multiplex digital PCR reaction system provided by an embodiment of the present invention. A is a 2D image of positive droplets for each gene target in the FAM and HEX channels, B is a 2D image of positive droplets for each gene target in the FAM and ROX channels, C is a 2D image of positive droplets for each gene target in the FAM and CY5 channels, D is a 2D image of positive droplets for each gene target in the HEX and ROX channels, E is a 2D image of positive droplets for each gene target in the HEX and CY5 channels, and F is a 2D image of positive droplets for each gene target in the ROX and CY5 channels.
[0047] Figure 5 This is a 1-dimensional graph of the linear results of positive droplets in each channel of the multiplex digital PCR reaction system provided by an embodiment of the present invention. Among them, A is the FAM channel, B is the HEX channel, C is the ROX channel, and D is the CY5 channel.
[0048] Figure 6 This is a statistical graph of the linear results of each target in the multiplex digital PCR reaction system provided by an embodiment of the present invention.
[0049] Figure 7This is a 1-dimensional graph of the reproducibility results of positive droplets in each channel of the multiplex digital PCR reaction system provided by an embodiment of the present invention. Among them, A is the FAM channel, B is the HEX channel, C is the ROX channel, and D is the CY5 channel.
[0050] Figure 8 This is a 1-dimensional comparison of the results of multiplex digital PCR and each single digital PCR provided in the embodiments of the present invention. A is a comparison of the results of the multiplex digital PCR and single digital PCR for the ASFV-VP72 gene target, B is a comparison of the results of the multiplex digital PCR and single digital PCR for the ASFV-CD2V gene target, C is a comparison of the results of the multiplex digital PCR and single digital PCR for the ASFV-14L gene target, D is a comparison of the results of the multiplex digital PCR and single digital PCR for the PRRSV-RdRP gene target, E is a comparison of the results of the multiplex digital PCR and single digital PCR for the PRRSV-European strain target, F is a comparison of the results of the multiplex digital PCR and single digital PCR for the PRRSV-American strain target, G is a comparison of the results of the multiplex digital PCR and single digital PCR for the CSFV-vaccine strain target, and H is a comparison of the results of the multiplex digital PCR and single digital PCR for the CSFV-wild strain target.
[0051] Figure 9 This figure compares the results of multiplex digital PCR and individual single digital PCR assays provided by an embodiment of the present invention. The coefficient of variation (CV) values for both the single and multiplex digital PCR assays are less than 2%, demonstrating good agreement between the multiplex digital PCR assay and the individual single digital PCR assays, with no cross-talk between the multiplex digital PCR assays. DETAILED DESCRIPTION
[0052] In order to make the purpose, technical solutions and advantages of the present invention more clearly understood, the present invention is further described in detail below in conjunction with the embodiments. It should be understood that the specific embodiments described herein are only used to explain the present invention and are not intended to limit the present invention.
[0053] The purpose of the present invention is to provide a digital PCR kit for simultaneously detecting African swine fever virus, blue ear virus, and classical swine fever virus, wherein the kit comprises primers and probes as shown in SEQ ID NO.1 to SEQ ID NO.24.
[0054] The embodiment of the present invention also provides a method for detecting African swine fever virus, blue ear virus, and classical swine fever virus for non-disease diagnosis or treatment purposes, comprising the following steps:
[0055] (1) Using the extracted nucleic acid of the sample to be tested as a template, the sample to be tested is amplified using primers such as SEQ ID NO. 1-2, SEQ ID NO. 4-5, SEQ ID NO. 7-8, SEQ ID NO. 10-11, SEQ ID NO. 13-14, SEQ ID NO. 16-17 and SEQ ID NO. 19-20, and the amplified product is identified by probes such as SEQ ID NO. 3, SEQ ID NO. 6, SEQ ID NO. 9, SEQ ID NO. 12, SEQ ID NO. 15, SEQ ID NO. 18 and SEQ ID NO. 21;
[0056] The probe shown in SEQ ID NO.3 has a FAM fluorescent label at its 5' end and an MGB fluorescent label at its 3' end; the probe shown in SEQ ID NO.6 has a FAM fluorescent label at its 5' end and an MGB fluorescent label at its 3' end; the probe shown in SEQ ID NO.9 has a CY5 fluorescent label at its 5' end and an MGB fluorescent label at its 3' end; the probe shown in SEQ ID NO.12 has a CY5 fluorescent label at its 5' end and a BHQ2 fluorescent label at its 3' end; the probe shown in SEQ ID NO.15 has a HEX fluorescent label at its 5' end and a BHQ1 fluorescent label at its 3' end; the probe shown in SEQ ID NO.18 has a HEX fluorescent label at its 5' end and a BHQ1 fluorescent label at its 3' end; the probe shown in SEQ ID NO.21 has a ROX fluorescent label at its 5' end and an MGB fluorescent label at its 3' end;
[0057] (2) simultaneously setting an IPC internal standard including primers and probes as shown in SEQ ID NO. 21 to SEQ ID NO. 24, wherein the 5' end of the probe as shown in SEQ ID NO. 24 is set with a ROX fluorescent label and the 3' end is set with an MGB fluorescent label; performing digital PCR fluorescence detection and collecting the signal of the fluorescence channel;
[0058] (3) Result analysis:
[0059] In the present invention, the concentrations are 10 3 A mixture of ASFV-VP72, ASFV-CD2V, ASFV-14L, PRRSV-RdRP, PRRSV-European strain, PRRSV-American strain, CSFV-epidemic-UTR, CSFV-toxic-UTR, and IPC internal standard recombinant plasmids with a concentration of 100 copies / μL was used as a positive control, and ultrapure water was used as a negative control.
[0060] Click "Analyze" on the biochip reader to analyze the experimental data. In the 2D or 1D plot, the darkest black dots represent negative droplets, and the remaining colored droplets represent positive droplets in the corresponding channels. The negative control should have no positive droplets, and the positive control should have positive droplets in all channels corresponding to the bands.
[0061] FAM channel band 1 represents African swine fever virus-CD2V gene-positive droplets, FAM channel band 2 represents African swine fever virus-VP72 gene-positive droplets, HEX channel band 1 represents porcine reproductive and respiratory syndrome virus-American strain, HEX channel band 2 represents porcine reproductive and respiratory syndrome virus-European strain, ROX channel band 1 represents porcine fever virus-vaccine strain, ROX channel band 2 represents porcine fever virus-field strain, ROX channel band 3 represents internal standard-positive droplets, CY5 channel band 1 represents African swine fever virus-14L gene-positive droplets, CY5 channel band 2 represents porcine reproductive and respiratory syndrome virus-RdRP gene-positive droplets ( Figure 3 );
[0062] Judgment of the same sample: If FAM channel band 1, band 2, and CY5 channel band 1 are all positive, it is judged to be infected with the wild strain of African swine fever virus. If a gene target is negative, it is judged to be a strain with a deletion of that gene; if CY5 channel band 2 and HEX channel band 1 are positive, it is judged to be infected with the American strain of porcine reproductive and respiratory syndrome virus; if CY5 channel band 2 and HEX channel band 2 are positive, it is judged to be infected with the European strain of porcine reproductive and respiratory syndrome virus; if ROX channel band 1 is positive, it is judged to be infected with the vaccine strain of porcine reproductive and respiratory syndrome virus, and if ROX channel band 2 is positive, it is judged to be infected with the wild strain of porcine reproductive and respiratory syndrome virus.
[0063] In some specific embodiments, the reaction system of the amplification reaction includes: 10 μL of digital PCR reaction premix, 1.45 μL of primer mix, 0.75 μL of probe mix, 2 μL of nucleic acid template, and ddH2O to 20 μL.
[0064] In some specific embodiments, the amplification reaction is as follows: pre-denaturation at 95°C for 10 min; denaturation at 94°C for 30 s, annealing and extension at 60°C for 1 min, 40 cycles; inactivation at 98°C for 10 min; cooling at 20°C for 2 min; and collecting fluorescence signals from four channels, namely, FAM, HEX, ROX, and CY5, at the end of each cycle.
[0065] Example 1 Design of primer and probe sequences
[0066] The complete genome sequence of African swine fever virus and the sequences of CD2V gene, VP72 gene, and 14L gene (GenBank numbers: OR660699.1, OR460741.1, KM609379.1, LR813622.1, MK686061.1, NC_044952.1, KM609357.1, MW748495.1, MH025920.1, O Z005803.1, OQ971726.1, NC_044941.1, MW736613.1, MT932578.1, MN270980.1, KX354450.1, KM102979.1, MW788406.1, NC_044946.1, MH025920.1, ON409980.1, NC_044953.1, MT932578.1, etc.); porcine reproductive and respiratory syndrome virus-RdRP gene or complete genome sequence (GU461292.1, MW366748.1 , GQ499195.1, JF748718.1, JQ663558.1, KM453699.1, JX826382.1, JX826378.1, JX826373.1, etc.); gene sequence of European strain of porcine reproductive and respiratory syndrome virus (MW053399.1, MW053395.1, MW448197.1, KY366411.1, etc.); gene sequence of American strain of porcine reproductive and respiratory syndrome virus (MG913987.1, JX317648.1, GQ857656.1, AY032626.1, GQ35 1601.1, GQ914997.1, AF535152.1, etc.); Classical Chinese Fever Virus - Vaccine Strain Gene Sequences (AF531433.1, AY805221.1, AF091507.1, AY663656.1, HM175885.1, Z46258.1, etc.); Classical Chinese Fever Virus - Wild-Type Strain Gene Sequences (AF092448.2, AY578688.1, KM262189.1, KY860615.2, MK121886.1, MN558885.1, X87939.1, etc.). The IPC internal standard is based on the conserved gene sequence of the rRNA gene in the porcine mitochondrial genome. After aligning the target gene sequences using SnapGene software, relatively conserved nucleotide sequences were selected for each pathogen. Primer and probe sequences were then designed based on primer and TaqMan probe design principles and in accordance with relevant national standards. The detection targets and sequences of the kit are summarized in Table 1 The designed primers and probes were delivered to Sangon Biotech Co., Ltd. for synthesis.
[0067] Table 1 Primers and probes for digital PCR kits for detecting African swine fever virus, porcine reproductive and respiratory syndrome virus, and classical swine fever virus
[0068]
[0069]
[0070] Example 2 Construction of plasmid standards
[0071] The gene sequences of African swine fever virus, porcine reproductive and respiratory syndrome virus (PRRSV), classical swine fever virus, and internal standard were synthesized by Sangon Biotechnology Co., Ltd. and named ASFV-VP72, ASFV-CD2V, ASFV-14L, PRRSV-RdRP, PRRSV-European strain, PRRSV-American strain, CSFV-epidemic-UTR, CSFV-toxic-UTR, and IPC internal standard, respectively. The plasmid DNA standards were then frozen at -80°C until use.
[0072] DNA copy number = (M × 6.02 × 10 23 ×10 -9 ) / (n×660)
[0073] M represents the plasmid DNA concentration, where n represents the recombinant plasmid length = T vector length + target fragment length.
[0074] 2.2 Establishment of standard curve for single-plex fluorescence PCR reaction system
[0075] To verify whether the amplification efficiency and correlation coefficient of the primer probes designed for each target meet the requirements for establishing a multiplex digital PCR system, the ASFV-VP72, ASFV-CD2V, and ASFV-14L positive plasmids of African swine fever virus (ASFV), the PRRSV-RdRP, PRRSV-European strain, and PRRSV-American strain positive plasmids of Porcine Reproductive and Respiratory Syndrome Virus (PRRSV), and the CSFV-epidemic-UTR and CSFV-toxic-UTR positive plasmids of Classical Swine Fever Virus (CSFV) were diluted 10-fold and then subjected to single-plex fluorescence PCR. The concentration standard curve was prepared using the template concentration fluorescence Ct value. The configuration of each reaction system is shown in Table 2. The fluorescence PCR reaction was performed according to the procedure shown in Table 3. The equipment used was a JLM QX600 from JLM.
[0076] Table 2 Preparation of single-plex fluorescence PCR reaction system
[0077]
[0078] Table 3 Fluorescence PCR reaction parameter settings
[0079]
[0080] ASFV-VP72, ASFV-CD2V, ASFV-14L, PRRSV-RdRP, PRRSV-European strain, PRRSV-American strain, CSFV-epidemic-UTR, CSFV-toxic-UTR positive plasmids were used to make concentration-Ct value standard curves ( Figure 1 ).from Figure 1 It can be seen that in the single-plex system, the standard curve PCR amplification efficiency E value, R and curve slope are all within the normal range, indicating that the amplification efficiency is good and can be used for the subsequent establishment of a multiplex digital PCR system.
[0081] 2.3 Specificity test
[0082] The ASFV-VP72, ASFV-CD2V, ASFV-14L, PRRSV-RdRP, PRRSV-European strain, PRRSV-American strain, CSFV-epidemic-UTR, and CSFV-toxic-UTR swine disease-related plasmids involved in this kit were selected for mutual specificity testing within the kit, and single fluorescence PCR was performed using primers and probes of ASFV-VP72, ASFV-CD2V, ASFV-14L, PRRSV-RdRP, PRRSV-European strain, PRRSV-American strain, CSFV-epidemic-UTR, and CSFV-toxic-UTR. At the same time, the positive plasmids of the ASFV-VP72, ASFV-CD2V, ASFV-14L, PRRSV-RdRP, PRRSV-European strain, PRRSV-American strain, CSFV-epidemic-UTR, and CSFV-toxic-UTR targets of this kit were used as positive controls, and ddH2O was used as a negative control. The system configuration is shown in Table 2. The final concentration of each target primer is 200 nmol / L, and the final concentration of the probe is 100 nmol / L. The fluorescence PCR reaction is performed according to the procedure shown in Table 3. The equipment used is JLM QX600 from JLM.
[0083] After testing, it was found that no amplification occurred between each target primer probe of this kit and the other target positive plasmids, and each positive showed fluorescence intensity, indicating that the detection primers and probes have good specificity and can be used for the construction of subsequent multiplex digital PCR systems. Figure 2 , Table 4. The plasmid concentrations in Table 4 are all 1.0×10 6 Copies / μL.
[0084] Table 4 Specificity test of each target single-plex system of this kit
[0085]
[0086] 2.1 Establishment of digital PCR multiplex reaction system
[0087] The primer and probe stock solutions were diluted and mixed thoroughly to prepare primer mixtures and probe mixtures. The final concentrations of each target primer are shown in Table 1. The configuration of each reaction system is shown in Table 5. The digital PCR reaction was performed according to the procedure shown in Table 6. The equipment used was JLM Digital Matrix-5000 digital PCR from JLM.
[0088] Sample concentration (copies / μL) = fixed value result (copies / μL) × 20 (total reaction system) ÷ 2 (sample volume).
[0089] Table 5 Preparation of digital PCR fixed value reaction system
[0090]
[0091] Table 6 Digital PCR reaction parameter settings
[0092]
[0093] 2.4 Establishment of digital PCR multiplex reaction system
[0094] The theoretical value of ASFV-VP72, ASFV-CD2V, ASFV-14L, PRRSV-RdRP, PRRSV-European strain, PRRSV-American strain, CSFV-epidemic-UTR, CSFV-toxic-UTR, and internal standard plasmid is 10 6 Nine positive plasmids (copies / μL) were mixed in equal volumes and linearized using QuickCut Sac I and QuickCut Kpn I. The enzyme digestion system is shown in Table 7. Digestion was completed by incubation at 37°C for 15 minutes.
[0095] Table 7 Plasmid linearization enzyme digestion system
[0096]
[0097] The 9 positive plasmids after enzyme digestion were tested according to the final concentrations of target primers and probes in Table 1, the reaction system in Table 5, and the reaction procedures in Table 6 obtained after the optimization system. The 1D diagram of the test results is shown in FIG. Figure 3 , 2D graph as Figure 4As shown, from the 1D graph, the bands between the targets of each channel are clearly layered and will not interfere with each other's detection. From the 2D graph, the targets are clearly distinguished and the bands are clearly divided. The 1D and 2D graphs have good effects. The experimental results prove that the multiplex digital PCR reaction system was successfully established.
[0098] 2.5 Establishment of the digital PCR multiplex reaction system standard curve and determination of the minimum detection limit
[0099] The theoretical concentration after enzyme digestion is 10 4 Digital PCR reactions were performed using seven 4-fold dilutions of the plasmid mixture (copies / μL). ddH2O was used as a negative control. The reaction system is shown in Table 5. Multiplex digital PCR reactions were performed according to the reaction conditions in Table 6 to evaluate the linearity and minimum detection limit of the method. Sample concentration (copies / μL) = calculated value (copies / μL) × 20 (total reaction volume) / 2 (sample load).
[0100] The digital PCR results showed that the number of droplets was greater than 10,000, which met the experimental analysis requirements. The correlation coefficient of the standard curve (R 2 ) are all greater than 0.98, and the linearity established by the multiplex digital PCR method meets the performance requirements. In the multiplex digital PCR system, the minimum detection limits of ASFV-VP72, ASFV-CD2V, ASFV-14L, PRRSV-RdRP, PRRSV-European strain, PRRSV-American strain, CSFV-epidemic-UTR, and CSFV-Toxic-UTR are 1.91Copies / μL, 2.93Copies / μL, 5.71Copies / μL, 6.69Copies / μL, 1.95Copies / μL, 0.98Copies / μL, 4.77Copies / μL, and 0.98Copies / μL, respectively. Results are shown in Figure 5 、 Figure 6 , Table 8.
[0101] Table 8 Statistics of the minimum detection limit test results of the multiplex digital PCR system of this kit
[0102]
[0103] 2.6 Repeatability test of digital PCR multiplex reaction system
[0104] Multiplex digital PCR reactions were performed using single copy number concentrations of five positive mixed plasmids. The test was repeated eight times, and the test results were statistically analyzed to calculate the coefficient of variation and evaluate the repeatability of the method.
[0105] Select 10 4Copies / μL were diluted 16 times and mixed with plasmid as a positive template. The results showed that the number of droplets was greater than 10,000, which met the experimental analysis requirements. The intra-group coefficient of variation was between 0.398% and 0.920%, which was less than 1%, indicating that the method had good repeatability. Figure 7 , as shown in Table 9.
[0106] Table 9 Statistics of repeatability test results for each target in the multiplex digital PCR system of this kit
[0107]
[0108] 2.7 Comparison of singleplex and multiplex digital PCR reaction systems
[0109] Single-copy concentrations of five positive mixed plasmids were used to perform single-plex and multiplex digital PCR reactions for each target. The 2% fixed concentrations corresponding to the same template concentration were compared, the coefficient of variation of the fixed results of the single-plex and multiplex systems was calculated, and the consistency of single-plex digital PCR and multiplex digital PCR was compared.
[0110] The results showed that the number of droplets was greater than 10,000, which met the experimental analysis requirements. The coefficient of variation of the copy number of single and multiplex fixed concentrations was less than 2%, indicating that the fixed concentration results of the single and multiplex digital PCR reaction systems for the same sample were not much different, which met the experimental requirements. The experimental results are as follows Figure 8 、 Figure 9 , as shown in Table 10.
[0111] Table 10 Comparative test results of single-plex and multiplex digital PCR systems of this kit
[0112]
[0113] After testing the single-plex system of African swine fever virus-VP72 gene, African swine fever virus-CD2V gene, African swine fever virus-14L gene, porcine reproductive and respiratory syndrome virus-RdRP gene, porcine reproductive and respiratory syndrome virus-European strain, porcine reproductive and respiratory syndrome virus-American strain, classical swine fever virus-vaccine strain, and classical swine fever virus-wild strain, a nine-plex digital PCR system including internal standards was established. After testing of indicators such as linearity, specificity, minimum detection limit, repeatability, and comparison of single-plex and multiplex digital PCR systems, the digital PCR multiplex detection kits currently developed fully meet development requirements.
[0114] 1. Specific application fields or related products of the present invention.
[0115] Application areas:
[0116] 1. Disease monitoring and purification in large-scale pig farms
[0117] Core needs: Outbreaks of African swine fever (ASFV) and porcine reproductive and respiratory syndrome (PRRSV) can result in up to 100% mortality in pig herds. Traditional detection methods (such as qPCR) require multiple tests for different pathogens, delaying prevention and control efforts.
[0118] Technical Advantages: A single nine-step test (completed within 5 hours) simultaneously screens for ASFV (VP72, CD2V, and 14L genes), PRRSV (European and American strains, RdRP gene), Classical Swine Fever Virus (vaccine and wild strains), and internal standards, accurately identifying latent infections (sensitivity ≤ 10 copies / μL). For example, if a positive ASFV-CD2V gene (virulence gene) is detected, isolation measures can be immediately initiated to prevent the spread of the virus.
[0119] Typical users: large breeding groups (such as Wens and Muyuan) and breeding bases for breeding pigs.
[0120] 2. Import and export quarantine of live pigs and pork products
[0121] Core demand: Major pork importing countries such as China and the European Union require a "zero tolerance" policy for ASFV, but the traditional detection process takes 3-5 days, resulting in customs clearance delays.
[0122] Technical Advantages: A single test covers all key ASFV genes (VP72, CD2V, and 14L), distinguishing wild-type strains from gene-deleted vaccine strains (such as the ASFV-CD2V deletion strain, commonly used in vaccine development), meeting the OIE's "single test, multiple determinations" requirement. Experimental data shows that this kit can complete sample testing within 5 hours, a 60% reduction compared to traditional methods, facilitating rapid customs clearance.
[0123] Typical users: customs quarantine departments, meat import and export companies (such as Shuanghui and WH Group).
[0124] 3. Quality control of pig vaccine and veterinary drug production
[0125] Core requirements: Residual viral nucleic acids in live vaccines may lead to immune failure or safety hazards, and high-sensitivity detection technology is required to monitor the production process.
[0126] Technical advantages: Detection of the PRRSV-RdRP gene (a key gene for viral replication) can evaluate the inactivation effect of the vaccine, with a sensitivity of less than 10 copies / μL, which is a hundred times higher than the ELISA method (sensitivity 1000 copies / μL).
[0127] Typical users: vaccine manufacturers such as Biostime and China Animal Husbandry Group.
[0128] 4. Virus contamination screening in slaughtering and processing
[0129] Core needs: Slaughterhouses need to ensure that pork products are free of ASFV contamination, but traditional methods cannot distinguish between nucleic acid residues before and after virus inactivation.
[0130] Technical advantages: Combined with the porcine mitochondrial rRNA internal standard (to detect sample freshness), it can be determined whether the virus is actively infected (the synchronous degradation of the internal standard and pathogenic DNA indicates that the sample has been treated with high temperature).
[0131] Typical users: food processing companies (such as Yurun and Jinluo).
[0132] 5. Wildlife disease tracing and ecological research
[0133] Core needs: Wild boars are an important host for the spread of ASFV, and efficient detection technology is needed to track virus mutations and transmission paths.
[0134] Technical advantages: The nine-fold detection can simultaneously analyze ASFV genotypes (such as CD2V mutations), PRRSV regional typing and host mitochondrial DNA, supporting the construction of virus evolutionary trees and transmission dynamics modeling.
[0135] Typical users: wildlife protection organizations, scientific research institutes (such as the Harbin Veterinary Research Institute of the Chinese Academy of Agricultural Sciences).
[0136] Based on the core technology solution, the following products and services can be developed to form a complete technology ecosystem:
[0137] 1. Core Products
[0138] Six-plex Digital PCR Detection Kit (Premix): Contains liquid or lyophilized microsphere primer probes, reaction buffer, and positive control. It is ready for use right out of the box and is compatible with mainstream digital PCR instruments (such as the Bio-Rad QX200 and Thermo Fisher QuantStudio 3D).
[0139] Multi-pathogen mixed quality control product: Contains inactivated virus particles of ASFV, PRRSV, CSFV and gradient concentration standards (1-10 5 copies / μL), used for laboratory standardization quality control and equipment calibration.
[0140] The above description is only a specific embodiment of the present invention, but the scope of protection of the present invention is not limited thereto. Any modifications, equivalent substitutions and improvements made by any technician familiar with this technical field within the technical scope disclosed by the present invention and within the spirit and principles of the present invention should be covered by the scope of protection of the present invention.
Claims
1. A digital PCR kit for simultaneous detection of African swine fever virus, porcine reproductive and respiratory syndrome virus, and classical swine fever virus, characterized in that: The kit comprises: (1) Primers and probes shown in SEQ ID NO. 1 to SEQ ID NO. 24; (2) IPC internal standards, including primers and probes shown in SEQ ID NO. 21 to SEQ ID NO. 24; (3) Digital PCR reaction premix 10 μL, primer mix 1.45 μL, probe mix 0.75 μL, nucleic acid template 2 μL, and ddH2O to 20 μL; (4) Marking methods include: The probes shown in SEQ ID NO. 3 and SEQ ID NO. 6 are fluorescently labeled with FAM at their 5' ends and MGB at their 3' ends; The probe shown in SEQ ID NO. 9 is fluorescently labeled with CY5 at its 5' end and MGB at its 3' end; The probe shown in SEQ ID NO. 12 is fluorescently labeled with CY5 at its 5' end and with BHQ2 at its 3' end; The probes shown in SEQ ID NO. 15 and SEQ ID NO. 18 were fluorescently labeled with HEX at their 5' ends and with BHQ1 at their 3' ends; The probes shown in SEQ ID NO. 21 and SEQ ID NO. 24 are fluorescently labeled with ROX at their 5' ends and with MGB at their 3' ends.
2. A digital PCR detection method, characterized in that: The following steps are involved: (1) extracting nucleic acid from the sample to be tested, amplifying it using the primer pairs shown in SEQ ID NO.1 to SEQ ID NO.20, and identifying the amplified product using the probes shown in SEQ ID NO.3, SEQ ID NO.6, SEQ ID NO.9, SEQ ID NO.12, SEQ ID NO.15, SEQ ID NO.18, and SEQ ID NO.21; (2) Setting an IPC internal standard, including primers and probes shown in SEQ ID NO. 21 to SEQ ID NO. 24; (3) Digital PCR fluorescence detection, collecting fluorescence signals from four channels: FAM, HEX, ROX, and CY5; (4) Amplification reaction conditions were as follows: pre-denaturation at 95°C for 10 min; denaturation at 94°C for 30 s, annealing and extension at 60°C for 1 min, 40 cycles; inactivation at 98°C for 10 min; and cooling at 20°C for 2 min.
3. The kit according to claim 1, wherein The primers and probes include any combination of SEQ ID NO.1 to SEQ ID NO.
24.
4. The kit according to claim 1, wherein The volume ratio of the primer mix and the probe mix is 1.45 μL:0.75 μL.
5. The method according to claim 2, characterized in that During the digital PCR fluorescence detection process, signals from the four channels of FAM, HEX, ROX, and CY5 are used to identify different targets, respectively.
6. The method according to claim 2, characterized in that Fluorescent label and probe matching includes: FAM labeling is used for the detection of African swine fever virus-CD2V gene and VP72 gene; The CY5 marker is used to detect the African swine fever virus-14L gene and the porcine reproductive and respiratory syndrome virus-RdRP gene; HEX markers are used to detect European and American strains of porcine reproductive and respiratory syndrome virus (PRRSV); ROX labeling is used for the detection of vaccine strains, wild strains and internal standards of classical swine fever virus.
7. The method according to claim 2, characterized in that At the end of each cycle, fluorescence signals of four channels, FAM, HEX, ROX, and CY5, were collected.
Citation Information
Patent Citations
Semiconductor structure and forming method for thereof
US20220102520A1
Dual real-time fluorescence detection primer probe group, kit and method of ASFV (African Swine Fever Virus) VP72 and CD2V genes
CN110791590A
Freeze-dried microporous plate, kit and method used for identifying African swine fever viruses, swine fever wild strains and hog cholera lapinized virus vaccine strains
CN111321247A
EMA-ddPCR primer and probe for detecting infectious ASFV and application
CN113502352A
Quadruple quantitative fluorescent probe primer combination, kit and identification method for identifying African swine fever wild virus and vaccine strain
CN113755565A
Cited By
Fluorescent RT-PCR (Reverse Transcription-Polymerase Chain Reaction) detection kit for dual identification of European and American porcine reproductive and respiratory syndrome viruses
CN121137271A